BOTOX Effects on Seizure Severity and Susceptibility
Phase 4
Terminated
NCT05605756
| Condition | Drug-resistant Focal Seizure |
|---|
| Phase | Phase 4 |
|---|
| Sponsor | Beth Israel Deaconess Medical Center |
|---|
| Status | Terminated |
|---|
| Enrollment | 3 participants |
|---|
| Interventions | OnabotulinumtoxinA 145 UNT [Botox] |
|---|
| Start date | Mar 1, 2023 |
|---|
| Completion date | Dec 1, 2024 |
|---|
| Results posted | Jun 29, 2026 |
|---|
Summary
The purpose of this research is to determine whether BOTOX injections will reduce seizure frequency and severity. We chose to test its effects on epilepsy because epilepsy and migraine have common features so, are often treated with common drugs.
Change in Net Cortical Excitability Metrics
150 days · Participants
| Botox Therapy Effects on Seizure | 0 Participants |
|---|
Open in BENITIONS
View on ClinicalTrials.gov
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.